ECSP11010772A - Inhibidor de infección - Google Patents

Inhibidor de infección

Info

Publication number
ECSP11010772A
ECSP11010772A EC2011010772A ECSP11010772A ECSP11010772A EC SP11010772 A ECSP11010772 A EC SP11010772A EC 2011010772 A EC2011010772 A EC 2011010772A EC SP11010772 A ECSP11010772 A EC SP11010772A EC SP11010772 A ECSP11010772 A EC SP11010772A
Authority
EC
Ecuador
Prior art keywords
protein
relates
white spot
virus
spot syndrome
Prior art date
Application number
EC2011010772A
Other languages
English (en)
Inventor
Justinus Maria Vlak
Original Assignee
Univ Wageningen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wageningen filed Critical Univ Wageningen
Publication of ECSP11010772A publication Critical patent/ECSP11010772A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/153—Nucleic acids; Hydrolysis products or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/18011—Nimaviridae
    • C12N2710/18022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Birds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se relaciona con una proteína de virus de Síndrome de Mancha blanca y a un virus de molécula de ácido nucléico de un Síndrome de Mancha Blanca que codifica a dicha proteína. También se relaciona con composiciones que comprenden dicha proteína, su uso en una vacuna, vacunas que comprenden dicha proteína y exámenes diagnósticos para la detección del virus especifico de ADN del Síndrome de Mancha blanca o material antigénico. Finalmente, se relaciona a anticuerpos contra dicha proteína.
EC2011010772A 2008-06-20 2011-01-20 Inhibidor de infección ECSP11010772A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08158717 2008-06-20

Publications (1)

Publication Number Publication Date
ECSP11010772A true ECSP11010772A (es) 2011-04-29

Family

ID=39916296

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2011010772A ECSP11010772A (es) 2008-06-20 2011-01-20 Inhibidor de infección

Country Status (5)

Country Link
CN (1) CN102046650A (es)
BR (1) BRPI0913246A2 (es)
EC (1) ECSP11010772A (es)
MX (1) MX2010013681A (es)
WO (1) WO2009153337A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109517037B (zh) * 2018-10-31 2022-02-08 青岛科技大学 具有白斑综合征病毒抑制作用的多肽及其应用
CN114088943B (zh) * 2021-12-01 2024-03-12 江苏省淡水水产研究所 一种用于检测克氏原螯虾白斑综合征病毒的金纳米探针及其制备方法和应用
CN114146071B (zh) * 2022-02-08 2023-02-28 西北农林科技大学深圳研究院 丹皮酚及其衍生物在预防和治疗白斑综合征中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1303942A (zh) * 1999-11-24 2001-07-18 国家海洋局第三海洋研究所 对虾白斑杆状病毒基因组DNA序列及c DNA序列
EP1664268A4 (en) * 2003-09-09 2008-09-03 Aqua Bounty Technologies Inc COMPOSITIONS AND METHODS FOR INHIBITING VIRUS INFECTION OF WHITE POINT DISEASE

Also Published As

Publication number Publication date
CN102046650A (zh) 2011-05-04
MX2010013681A (es) 2011-04-11
WO2009153337A1 (en) 2009-12-23
BRPI0913246A2 (pt) 2016-01-19

Similar Documents

Publication Publication Date Title
EA201071087A1 (ru) Моноклональные антитела, способные взаимодействовать с множеством подтипов вируса гриппа а
CY1118492T1 (el) Φαρμακοτεχνικες μορφες εμβολιου norovirus
CY1119284T1 (el) ΣΩΜΑΤΙΔΙΑ ΠΑΡΟΜΟΙΑ ΜΕ ΙΟ ΓΛΥΚΟ-ΠΡΩΤΕΪΝΗΣ ΛΥΣΣΑΣ (VLPs)
WO2008039267A3 (en) Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions
CY1121632T1 (el) Η rv2386c πρωτεϊνη φυματιωσης, συνθεσεις και χρησεις αυτης
CR20120042A (es) Inmunoconjugados dirigidos
AR071220A1 (es) Astrovirus aviario depositado bajo el nuero cncm i-3895
BR112014004860A2 (pt) composições de anticorpo contra vírus da influenza
EA201071365A1 (ru) Моноклональные антитела, имеющие гомоподтип кросс-нейтрализующих свойств против вируса гриппа а подтипа н1
WO2014134561A3 (en) Quantification of vaccine compositions
MX348152B (es) Anticuerpo monoclonal humano con especificidad para el virus del dengue serotipo 1 proteina e y sus usos.
AR066395A1 (es) Reovirus que tienen secuencias modificadas
CL2011003273A1 (es) Antígeno del virus respiratorio sincicial (vrs) recombinante, que comprende un polipéptido de proteína f soluble con una modificación que altera su glicosilación y que a su vez comprende un dominio f1 y un dominio f2 de proteína f de vrs; composición inmunogénica que lo comprende; ácido nucleico que lo codifica; vector; célula hospedera; método para producir dicho antígeno del vrs; y su uso para tratar una infección de vrs.
EA200970533A1 (ru) Жидкие композиции антител против бешенства
CO6260103A2 (es) Composiciones que comprenden antigenos neumococidos
CY1118153T1 (el) Αγωγη μικροβιακων μολυνσεων
CO6630164A2 (es) Proteinas que se unen al tnf-a
PE20160528A1 (es) Anticuerpos
CL2008002092A1 (es) Conjugado que contiene dos o mas peptidos antifusogenicos y un anticuerpo anti-cd-4; metodo de produccion; composicion farmaceutica que lo comprende; polipeptidos antifusogenicos y uso del conjugado para tratar infecciones viricas.
CO6210756A2 (es) La proteina linfopoyetina estromal timica canina y usos de la misma
UY33297A (es) Composiciones farmaceuticas que comprenden un polipéptido que comprende al menos un motivo cxxc y antígenos heterólogos y usos de las mismas
EA201001045A1 (ru) Модифицированный вирус гриппа
CO6440541A2 (es) Virus de diarrea viral bovina con una proteina erns modificada
BR112014029274A2 (pt) anticorpo isolado, composição farmacêutica, uso do anticorpo, método para tratar infecção rábica, kit para tratar infecção rábica, kit para detectar vírus rábico, ácido nucleico isolado, e, célula hospedeira.
CL2012002900A1 (es) Secuencias de acido nucleico procedente de un virus causante del sindrome de miocardiopatia (cms) en peces; vector; celula huesped; vacuna de adn; proteina recombinante codificada; vacuna recombinante; inmunoensayo para la deteccion de dicho virus; kit de diagnostico; y uso de las mismas.